Bharat Parenterals Ltd. (BPLPHARMA): Bharat Parenterals Share Price Rises 13.30% to Rs 2,147.10

Published: 28 September 2026 at 9:19:38 AM IST

Bharat Parenterals Share Price moved higher today, with the stock closing at Rs 2,147.10 after rising 13.30% from the previous close of Rs 1,895.10. The company’s market capitalisation stands at Rs 1,306.1 crore, placing the day’s move in the context of a relatively compact listed franchise within Healthcare. The session opened at Rs 2,050.00, touched Rs 2,174.50, and also recorded the same level as the day’s low, which makes the price action easy to read from the supplied data. The verified numbers confirm a sharp share price rise, but they do not establish a company-specific catalyst. For readers tracking Bharat Parenterals Share Price Today, the useful next step is to watch how the stock trades around the day’s range, how the valuation compares with peers, and whether the reported fundamentals support the move.

Bharat Parenterals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,147.1
Previous Close	Rs 1,895.1
Today's Move	Rs 252 (+13.3%)
Open	Rs 2,050
High	Rs 2,174.5
Low	Rs 2,050
Turnover	Rs 0.34 crore
Market Capitalisation	Rs 1,306.1 crore
Market Cap Category	Small Cap

Bharat Parenterals Ltd. (BPLPHARMA) rose to Rs 2,147.1 from the previous close of Rs 1,895.1, a move of Rs 252 or 13.3%. The stock opened at Rs 2,050, reached a high of Rs 2,174.5, recorded a low of Rs 2,050.

Bharat Parenterals Share Price rose Rs 252.00 on the day to Rs 2,147.10, translating into a 13.30% gain over the previous close of Rs 1,895.10. The stock opened at Rs 2,050.00 and moved to a high of Rs 2,174.50, while the low for the session was also Rs 2,050.00. Turnover stood at Rs 0.34 crore. In simple terms, today’s Bharat Parenterals Share Price move was a clear same-day price rise, and the supplied data confirms the event without identifying a separate trigger. For Bharat Parenterals Stock News readers, the verified point is the scale of the change, not a narrative about why it happened. That keeps Bharat Parenterals Share Price Today coverage factual and aligned with the available market data.

Bharat Parenterals Ltd. (BPLPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,306.1 crore
P/B Ratio	4.1x
ROE	-8.36%
ROCE	-1.82%
EPS	Rs -22.35
Book Value Per Share	Rs 462.38
Dividend Yield	0.05%

Bharat Parenterals Ltd. (BPLPHARMA) fundamental metrics show P/B 4.1x, ROE -8.36%, ROCE -1.82%. These figures provide context only and are not a buy or sell signal.

Bharat Parenterals Ltd. has a market capitalisation of Rs 1306.1 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 4.1x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -8.36% and ROCE of -1.82%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs -22.35, book value per share of Rs 462.38, dividend yield of 0.05%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.48%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Benchmark Median P/E	32.87x
Benchmark Average P/E	49.63x
Benchmark P/E Range	3.46x to 735.85x
Company P/B Ratio	4.1x
Benchmark Median P/B	2.85x
Company ROE	-8.36%
Benchmark Median ROE	11.48%
Company ROCE	-1.82%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 1,306.1 crore
Benchmark Median Market Cap	Rs 732.57 crore

Bharat Parenterals Ltd. (BPLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Bharat Parenterals Ltd. (BPLPHARMA) has a ROE of -8.36%, which is below the benchmark median of 11.48%, a difference of -172.82%. Bharat Parenterals Ltd. (BPLPHARMA) has a ROCE of -1.82%, which is below the benchmark median of 13.17%, a difference of -113.82%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	36.77	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,55,115.31	87.22	14.44	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,613.38	86.94	21.13	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,19,899.96	26.57	4.45	19.69	21.39
Cipla Ltd.	CIPLA	1,12,875.68	33.49	3.21	11.83	16

Its ROE of -8.36% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at -1.82% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Bharat Parenterals Ltd. (BPLPHARMA) has a market capitalisation of Rs 1,306.1 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Bharat Parenterals

• Bharat Parenterals Share Price rose 13.30% today to Rs 2,147.10.
• The stock moved Rs 252.00 above the previous close of Rs 1,895.10.
• Market capitalisation is Rs 1,306.1 crore, which is above the industry median of Rs 732.57 crore.
• P/B is 4.1, compared with the sector median of 2.85 and average of 4.33.
• ROE is -8.36% and ROCE is -1.82%, so Bharat Parenterals Fundamental Analysis remains important to monitor.

About Bharat Parenterals

Bharat Parenterals Ltd. is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. Based on the supplied classification, it is a listed pharmaceutical business whose Bharat Parenterals Share Price is followed in the context of sector valuations, profitability and market capitalisation. The company’s current market capitalisation of Rs 1,306.1 crore places it within a clearly defined listed universe, while its book value of Rs 462.38 and EPS of Rs -22.35 provide direct accounting context for Bharat Parenterals Share Price Today readers. The dividend yield of 0.05% is also part of the factual snapshot. For Bharat Parenterals Stock News and Bharat Parenterals Share News searches, the key point is that the company belongs to a large and diverse pharmaceutical industry where peer comparison is essential, especially when profitability metrics are negative and valuation sits near sector averages. Univest presents this company context so readers can place the day’s move against business basics and market structure.

Track Bharat Parenterals Share Price on Univest

Use Bharat Parenterals Ltd. (BPLPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Bharat Parenterals Share Price on Univest for live price updates, company ratios, shareholding pattern, 52-week levels and market insights. The platform also helps follow Bharat Parenterals Share Price Today alongside valuation, peer comparison and company fundamentals in one place. For anyone scanning Bharat Parenterals Stock Analysis, Univest keeps the coverage connected and easy to revisit.

Frequently Asked Questions

Why did Bharat Parenterals Share Price rise today?

Ans. The data confirms a 13.30% same-day rise to Rs 2,147.10, but it does not establish a company-specific catalyst. The article therefore treats the move as a verified price event rather than a explained announcement-driven reaction.

What is Bharat Parenterals Share Price today?

Ans. Bharat Parenterals Share Price today is Rs 2,147.10. The stock gained Rs 252.00 from the previous close of Rs 1,895.10, making it one of the sharper same-day moves in the supplied data.

What is Bharat Parenterals market capitalisation?

Ans. Bharat Parenterals has a market capitalisation of Rs 1,306.1 crore. That places the company above the industry median market cap in the supplied benchmark set, while still far below several large healthcare peers.

How does Bharat Parenterals compare on valuation?

Ans. Bharat Parenterals reports a P/B ratio of 4.1, which is slightly above the sector median of 2.85 and close to the sector average of 4.33. This gives Bharat Parenterals Share Price useful valuation context.

What do Bharat Parenterals profitability metrics show?

Ans. The company reports ROE of -8.36%, ROCE of -1.82% and EPS of Rs -22.35. Those figures indicate negative profitability in the supplied snapshot, so Bharat Parenterals Fundamental Analysis stays important.

What is Bharat Parenterals book value?

Ans. Bharat Parenterals book value is Rs 462.38 per share. When paired with the current market price, it helps readers compare Bharat Parenterals Share Price with accounting net worth rather than price alone.

How does Bharat Parenterals compare with sector peers?

Ans. Compared with peers such as Sun Pharma, Divi’s Laboratories and Cipla, Bharat Parenterals is much smaller by market cap. Its P/B is near the sector range, but return ratios are below the benchmark.

Should investors track Bharat Parenterals Share Price on Univest?

Ans. Yes, Univest lets readers track Bharat Parenterals Share Price, valuation ratios, shareholding pattern and market context in one place. That makes it easier to review today’s move alongside the company’s broader financial snapshot.